All updates
All updates
today 47临床试验登记评分3434 临床试验登记评分3434 Phase 3 Evaluation of Sovateltide for the Treatment of Acute Traumatic Brain Injury
临床试验登记评分3535 Phase III Clinical Trial of Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)
临床试验登记评分2525 Phase 1 Trial of ACE723, A Dual-Payload Antibody Drug Conjugate, in Patients With Advanced HCC Who Have Failed or Progressed on Standard Systemic Therapy Containing ICIs
临床试验登记评分2626 Labyrinthin Vaccination in Veterans With Lung Adenocarcinoma
临床试验登记评分2727 Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma With Pirtobrutinib in Combination With Epcoritamab if the Disease Comes Back After Previous Treatment.
BioPharma Dive评分6969 ArriVent collapses on disappointing lung cancer data
JAMA评分4545 Iron or Multiple Micronutrient Powder Supplements With Malaria Chemoprevention in Rural Malawian Children Research Summary
JAMA评分1212 Managing Chronic Subdural Hematoma With EMMA—Reply
JAMA评分4040 Trials Test Phage Therapy for UTIs
BioPharma Dive评分8585 Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial
BioSpace精选评分8787 AbbVie, Genmab's Epkinly sets ‘new standard of care’ in first-line lymphoma in Phase 3
中文产业新闻Chinese source评分6868 ArriVent伏美替尼一线 EGFR 20ins 全球 III 期 FURVENT 试验未达 PFS 主要终点
中文产业新闻精选Chinese source评分7878 MAIA最终分析：D-Rd方案较Rd在不适合移植NDMM患者中位OS延长26.2个月
中文产业新闻精选Chinese source评分7171 《柳叶刀》发表MATTERHORN与ASTRUM-006数据，围手术期免疫化疗在胃食管癌中确立全球地位
中文产业新闻精选Chinese source评分7676 依康坦博妥塔单抗TAISHAN-302 III期数据WCLC全体大会首发并同步发表NEJM
监管与产业动态精选评分7373 Vaxcyte’s Phase III data strengthen case for broader pneumococcal coverage
监管与产业动态评分3636 Genmab’s latest phase 2 data spur claim ADC is ‘clearly superior’ to AbbVie’s Elahere - Fierce Biotech
监管与产业动态评分3030 Vaxcyte’s stock jumps as pneumococcal vaccine holds its own against Pfizer's, Merck’s shots - Fierce Biotech
中文产业新闻Chinese source评分6464 Vaxcyte VAX-31三期临床成功，31价肺炎结合疫苗股价大涨31%
顶刊论文（社媒热度）精选评分8484 Obexelimab for the Treatment of IgG4-Related Disease.
中文产业新闻Chinese source评分3131 Genentech启动GDC-7035针对KRAS G12D突变结直肠癌和胰腺导管腺癌的Ib期临床试验
临床试验登记评分2424 A Study to Evaluate COR-2003 as Monotherapy and Co-Administered With COR-1004 in Adult Volunteers
临床试验登记评分2525 Phase I Study of In Vivo CAR-Tumor Technology for the Treatment of Advanced Malignant Tumors
临床试验登记评分2727 Reduction of Neoadjuvant Treatment in Early Triple-Negative Breast Cancer
临床试验登记评分2626 CLEAR-Lung III: Circulating Tumor DNA-Guided Consolidation Chemotherapy and Immunotherapy
临床试验登记评分2222 SI-B036-ST-101 in Advanced/Metastatic Solid Tumors
临床试验登记评分3232 A Study to Evaluate the Safety and Activity of GDC-7035 With Anti-Cancer Therapies in Participants With KRAS G12D-Mutated Unresectable Advanced or Metastatic Colorectal Cancer or Pancreatic Ductal Adenocarcinoma
临床试验登记评分2727 Trastuzumab/Pertuzumab With Fulvestrant and Kurmoxilil in HR+/HER2+ Early Breast Cancer
临床试验登记评分2222 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SYS6088 in Patients With Advanced/Metastatic Solid Tumors
中文产业新闻精选Chinese source评分6868 Vaxcyte 31价肺炎球菌结合疫苗VAX-31三期OPUS-1达主要终点
中文产业新闻精选Chinese source评分4444 Kodiak Sciences两款候选药DAYBREAK III期均达主要终点 股价一夜暴涨178%
社区讨论（Reddit）精选评分5656 The Lord of the Incretins: The Reign of Retatrutide... [Latest Research Update]
BioSpace评分5353 Vaxcyte rises as pneumococcal shot establishes ‘new competitive moat’ vs. Pfizer, Merck
BioSpace精选评分4747 Biogen’s big lupus bet gets boost from new durability data for skin disease
STAT News评分2525 STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more
STAT News评分1818 Could we one day vaccinate against every cancer?
STAT News评分5151 STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market
监管与产业动态评分2323 Simultaneous immune checkpoint blockade-associated diabetes mellitus and thyrotoxicosis
监管与产业动态评分1818 At-home subcutaneous atezolizumab for non-small cell lung cancer: a prospective, single-arm phase II feasibility study